作者：
Thomas M,Carroll [1]
;
Joseph A,Chadwick [1]
;
Richard P,Owen [1]
;
Michael J,White [1]
;
Joseph,Kaplinsky [1]
;
Iliana,Peneva [2]
;
Anna,Frangou [3]
;
Phil F,Xie [1]
;
Jaeho,Chang [1]
;
Andrew,Roth [4]
;
Bob,Amess [1]
;
Sabrina A,James [1]
;
Margarida,Rei [1]
;
Hannah S,Fuchs [1]
;
Katy J,McCann [5]
;
Ayo O,Omiyale [1]
;
Brittany-Amber,Jacobs [1]
;
Simon R,Lord [6]
;
Stewart,Norris-Bulpitt [7]
;
Sam T,Dobbie [8]
;
Lucinda,Griffiths [8]
;
Kristen Aufiero,Ramirez [9]
;
Toni,Ricciardi [9]
;
Mary J,Macri [9]
;
Aileen,Ryan [9]
;
Ralph R,Venhaus [9]
;
Benoit J,Van den Eynde [10]
;
Ioannis,Karydis [11]
;
Benjamin,Schuster-Böckler [1]
;
Mark R,Middleton [12]
;
Xin,Lu [13]
;
LUD2015-005 Project Team
作者单位：
Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK.
[1]
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
[2]
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK.
[3]
Department of Pathology and Molecular Medicine, University of British Columbia, Vancouver, Canada; Department of Computer Science, University of British Columbia, Vancouver, Canada; Department of Molecular Oncology, BC Cancer, Vancouver, Canada.
[4]
Cancer Research UK Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
[5]
Department of Oncology, University of Oxford, Oxford, UK.
[6]
Early Phase Clinical Trials Unit, Cancer & Haematology Centre, Churchill Hospital, Oxford, UK.
[7]
Oncology Clinical Trials Office (OCTO), Department of Oncology, University of Oxford, Oxford, UK.
[8]
Ludwig Cancer Research, New York, NY, USA.
[9]
Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK; Ludwig Institute for Cancer Research, Brussels, Belgium; de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
[10]
Cancer Sciences Unit, University of Southampton and Cancer Care Group, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
[11]
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK; Early Phase Clinical Trials Unit, Cancer & Haematology Centre, Churchill Hospital, Oxford, UK. Electronic address: mark.middleton@oncology.ox.ac.uk.
[12]
Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK. Electronic address: xin.lu@ludwig.ox.ac.uk.
[13]
DOI
10.1016/j.ccell.2023.06.006
PMID
37433281
发布时间
2024-03-20
换一批
换一批
